| __timestamp | Cytokinetics, Incorporated | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 44426000 | 56369000000 |
| Thursday, January 1, 2015 | 46398000 | 62786000000 |
| Friday, January 1, 2016 | 59897000 | 62427000000 |
| Sunday, January 1, 2017 | 90296000 | 62453000000 |
| Monday, January 1, 2018 | 89135000 | 65724000000 |
| Tuesday, January 1, 2019 | 86125000 | 70421000000 |
| Wednesday, January 1, 2020 | 96951000 | 80591000000 |
| Friday, January 1, 2021 | 159938000 | 86645000000 |
| Saturday, January 1, 2022 | 240813000 | 100551000000 |
| Sunday, January 1, 2023 | 330123000 | 42907000000 |
| Monday, January 1, 2024 | 115557000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. Dr. Reddy's Laboratories Limited, a global pharmaceutical giant, and Cytokinetics, Incorporated, a biopharmaceutical innovator, present a fascinating study in contrasts. From 2014 to 2023, Dr. Reddy's consistently reported a cost of revenue exceeding $40 billion annually, peaking at over $100 billion in 2022. This reflects their expansive global operations and diverse product portfolio. In contrast, Cytokinetics, with a more focused pipeline, saw its cost of revenue grow from $44 million in 2014 to $330 million in 2023, marking a staggering 646% increase. This growth underscores their strategic investments in research and development. Notably, 2024 data for Cytokinetics is missing, highlighting potential reporting delays or strategic shifts. As these companies navigate the complexities of the pharmaceutical industry, their financial trajectories offer valuable insights into their operational strategies and market positioning.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Cytokinetics, Incorporated
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited
Analyzing Cost of Revenue: Viatris Inc. and Cytokinetics, Incorporated
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.
Grifols, S.A. vs Cytokinetics, Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Cytokinetics, Incorporated vs Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Geron Corporation
Cost Insights: Breaking Down Cytokinetics, Incorporated and Amphastar Pharmaceuticals, Inc.'s Expenses